Antibody–PROTAC conjugates enable HER2-dependent targeted protein degradation of BRD4 - Maneiro, M; Forte, N; Shchepinova, MM; Kounde, CS; Chudasama, V; Baker, JR; Tate, EW (ACS Chemical Biology, 2020)